Literature DB >> 28369361

Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease.

Takanori Asakura1,2, Nobutaka Hayakawa3, Naoki Hasegawa4, Ho Namkoong1,5, Ken Takeuchi3, Shoji Suzuki1, Makoto Ishii1, Tomoko Betsuyaku1, Yoshiaki Abe3, Motofumi Ouchi3.   

Abstract

BACKGROUND: Pulmonary resection along with multiple antimicrobial therapy has produced favorable outcomes at a few centers. However, little is known regarding the risk factors for long-term survival and microbiological recurrence after pulmonary resection for nontuberculous mycobacterial pulmonary disease (NTMPD). We evaluated the long-term outcomes of pulmonary resection, including microbiological recurrence and survival.
METHODS: This retrospective cohort study included 125 patients (median age, 60 years) with NTMPD treated by pulmonary resection at two referral centers between January 1994 and August 2015.
RESULTS: Postoperative complications occurred in 27 patients (22%). The complication rate after pneumonectomy was significantly higher than those after other types of pulmonary resection (odds ratio, 4.1; 95% confidence interval [CI], 1.6-10.3; P = .005). The median follow-up period was 7.1 years. While 19 patients experienced microbiological recurrence, 26 died. Multivariate analysis revealed pneumonectomy (adjusted hazard ratio [aHR], 0.12; 95% CI, .007-.66; P = .0098) and cavitary lesions after surgery (aHR, 6.73; 95% CI, 1.68-22.7; P = .0095) to be predictors of microbiological recurrence and old age (aHR, 1.06; 95% CI, 1.01-1.13; P = .016), low body mass index (BMI; aHR for every 1-kg/m2 increase, 0.72; 95% CI, .60-.85; P < .0001), pneumonectomy (aHR, 4.38; 95% CI, 1.78-11.3; P = .014), and remnant cavitary lesions (aHR, 3.53; 95% CI, 1.35-9.57; P = .011) to be predictors of poor prognosis.
CONCLUSIONS: Patients who could benefit from pulmonary resection should be carefully selected considering age, BMI, remnant lesions after surgery, and type of pulmonary resection.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com

Entities:  

Keywords:  cavitary lesions; mycobacterium avium complex (MAC); nontuberculous mycobacteria (NTM); pneumonectomy; pulmonary resection

Mesh:

Substances:

Year:  2017        PMID: 28369361     DOI: 10.1093/cid/cix274

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  ERS International Congress 2021: highlights from the Respiratory Infections Assembly.

Authors:  Oliver W Meldrum; Kylie B R Belchamber; Kiarina D Chichirelo-Konstantynovych; Katie L Horton; Tetyana V Konstantynovych; Merete B Long; Melissa J McDonnell; Lidia Perea; Alberto L Garcia-Basteiro; Michael R Loebinger; Raquel Duarte; Holly R Keir
Journal:  ERJ Open Res       Date:  2022-05-23

2.  Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.

Authors:  Kelly M Pennington; Ann Vu; Douglas Challener; Christina G Rivera; F N U Shweta; John D Zeuli; Zelalem Temesgen
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-05-08

Review 3.  Surgery in nontuberculous mycobacteria pulmonary disease.

Authors:  Mimi Lu; Dominic Fitzgerald; Jonathan Karpelowsky; Hiran Selvadurai; Chetan Pandit; Paul Robinson; Ben J Marais
Journal:  Breathe (Sheff)       Date:  2018-12

4.  Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients.

Authors:  Hung-Ling Huang; Chia-Jung Liu; Meng-Rui Lee; Meng-Hsuan Cheng; Po-Liang Lu; Jann-Yuan Wang; Inn-Wen Chong
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

5.  Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease.

Authors:  Joong-Yub Kim; Samina Park; In Kyu Park; Chang Hyun Kang; Young Tae Kim; Jaemoon Koh; Jae-Joon Yim; Nakwon Kwak
Journal:  BMC Pulm Med       Date:  2021-10-06       Impact factor: 3.317

Review 6.  Non-tuberculous mycobacteria pulmonary disease: A review of trends, risk factors, diagnosis and management.

Authors:  L Nqwata; A R Ouédrago
Journal:  Afr J Thorac Crit Care Med       Date:  2022-07-15

7.  High mortality in patients with Mycobacterium avium complex lung disease: a systematic review.

Authors:  Roland Diel; Marc Lipman; Wouter Hoefsloot
Journal:  BMC Infect Dis       Date:  2018-05-03       Impact factor: 3.090

8.  The impact of adjuvant surgical treatment of nontuberculous mycobacterial pulmonary disease on prognosis and outcome.

Authors:  Kiyoharu Fukushima; Mari Miki; Yuki Matsumoto; Emi Uda; Yuji Yamamoto; Yuya Kogita; Yuko Kagawa; Takanori Matsuki; Hiroyuki Kagawa; Yohei Oshitani; Daisuke Motooka; Kazuyuki Tsujino; Kenji Yoshimura; Keisuke Miki; Akio Hayashi; Shota Nakamura; Seigo Kitada; Yukiyasu Takeuchi; Hiroshi Kida
Journal:  Respir Res       Date:  2020-06-16

9.  Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease.

Authors:  Kazuma Yagi; Takanori Asakura; Ho Namkoong; Shoji Suzuki; Takahiro Asami; Satoshi Okamori; Tatsuya Kusumoto; Yohei Funatsu; Hirofumi Kamata; Tomoyasu Nishimura; Makoto Ishii; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2018-07-13       Impact factor: 3.317

10.  Bronchoscopy as a Useful Examination for Determining Surgical Treatment Indications in Refractory Mycobacterium avium Complex Lung Disease Patients with Bilateral Lesions.

Authors:  Erina Tabata; Akimasa Sekine; Eri Hagiwara; Michihiko Tajiri; Takashi Ogura
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.